1 |
Amornsiripanitch N, Bickelhaupt S, Shin HJ, et al. Diffusion-weighted MRI for unenhanced breast cancer screening. Radiology 2019;293:504-520
DOI
|
2 |
Durur-Subasi I. DW-MRI of the breast: a pictorial review. Insights Imaging 2019;10:61
DOI
|
3 |
Brandao AC, Lehman CD, Partridge SC. Breast magnetic resonance imaging: diffusion-weighted imaging. Magn Reson Imaging Clin N Am 2013;21:321-336
DOI
|
4 |
Partridge SC, McDonald ES. Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am 2013;21:601-624
DOI
|
5 |
McDonald ES, Hammersley JA, Chou SH, et al. Performance of DWI as a rapid unenhanced technique for detecting mammographically occult breast cancer in elevated-risk women with dense breasts. AJR Am J Roentgenol 2016;207:205-216
DOI
|
6 |
Shin HJ, Chae EY, Choi WJ, et al. Diagnostic performance of fused diffusion-weighted imaging using unenhanced or postcontrast T1-weighted MR imaging in patients with breast cancer. Medicine (Baltimore) 2016;95:e3502
DOI
|
7 |
Hahn SY, Ko ES, Han BK, Lim Y, Gu S, Ko EY. Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer. Medicine (Baltimore) 2016;95:e4086
DOI
|
8 |
Amornsiripanitch N, Partridge S, Shin HJ. Diffusion MRI as a stand-alone unenhanced breast imaging approach and screening. In Iima M, Partridge SC, Le Bihan D. Diffusion MRI of the breast. Elsevier Health Sciences, 2022.
|
9 |
Ha SM, Chang JM, Lee SH, et al. Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer. Breast Cancer Res Treat 2020;182:283-297
DOI
|
10 |
Partridge SC, Nissan N, Rahbar H, Kitsch AE, Sigmund EE. Diffusion-weighted breast MRI: clinical applications and emerging techniques. J Magn Reson Imaging 2017;45:337-355
DOI
|
11 |
Jeong EH, Choi EJ, Choi H, Park EH, Song JS. Prediction of axillary lymph node metastasis in early breast cancer using dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging. Investig Magn Reson Imaging 2019;23:125-135
DOI
|
12 |
Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009;193:1716-1722
DOI
|
13 |
Trimboli RM, Verardi N, Cartia F, Carbonaro LA, Sardanelli F. Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study. AJR Am J Roentgenol 2014;203:674-681
DOI
|
14 |
Bickelhaupt S, Laun FB, Tesdorff J, et al. Fast and noninvasive characterization of suspicious lesions detected at breast cancer X-ray screening: capability of diffusion-weighted MR imaging with MIPs. Radiology 2016;278:689-697
DOI
|
15 |
Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103:1898-1905
DOI
|
16 |
Durur-Subasi I, Durur-Karakaya A, Karaman A, Seker M, Demirci E, Alper F. Is the necrosis/wall ADC ratio useful for the differentiation of benign and malignant breast lesions? Br J Radiol 2017;90:20160803
DOI
|
17 |
Yabuuchi H, Matsuo Y, Sunami S, et al. Detection of nonpalpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 2011;21:11-17
DOI
|
18 |
Kim JY, Suh HB, Kang HJ, et al. Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status. Breast Cancer Res Treat 2016;157:31-40
DOI
|
19 |
Rahbar H, Zhang Z, Chenevert TL, et al. Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res 2019;25:1756-1765
DOI
|
20 |
Kang JW, Shin HJ, Shin KC, et al. Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening. Breast Cancer Res Treat 2017;165:119-128
DOI
|
21 |
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89
DOI
|
22 |
Baltzer PAT, Bickel H, Spick C, et al. Potential of noncontrast magnetic resonance imaging with diffusion-weighted imaging in characterization of breast lesions: intraindividual comparison with dynamic contrast-enhanced magnetic resonance imaging. Invest Radiol 2018;53:229-235
DOI
|
23 |
Pinker K, Moy L, Sutton EJ, et al. Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging. Invest Radiol 2018;53:587-595
DOI
|
24 |
Youk JH, Son EJ, Chung J, Kim JA, Kim EK. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol 2012;22:1724-1734
DOI
|
25 |
Lee SH, Shin HJ, Moon WK. Diffusion-weighted magnetic resonance imaging of the breast: standardization of image acquisition and interpretation. Korean J Radiol 2021;22:9-22
DOI
|
26 |
Shin HJ, Lee SH, Park VY, et al. Diffusion-weighted magnetic resonance imaging for breast cancer screening in high-risk women: design and imaging protocol of a prospective multicenter study in Korea. J Breast Cancer 2021;24:218-228
DOI
|
27 |
Radovic N, Ivanac G, Divjak E, Biondic I, Bulum A, Brkljacic B. Evaluation of breast cancer morphology using diffusion-weighted and dynamic contrast-enhanced MRI: intermethod and interobserver agreement. J Magn Reson Imaging 2019;49:1381-1390
DOI
|
28 |
Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 2010;31:562-570
DOI
|
29 |
Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis. Acta Radiol 2016;57:651-660
DOI
|
30 |
Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008;18:1307-1318
DOI
|
31 |
Baltzer P, Mann RM, Iima M, et al. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 2020;30:1436-1450
DOI
|
32 |
Pereira FP, Martins G, Carvalhaes de Oliveira Rde V. Diffusion magnetic resonance imaging of the breast. Magn Reson Imaging Clin N Am 2011;19:95-110
DOI
|
33 |
Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 2010;20:1101-1110
DOI
|
34 |
McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015;275:772-782
DOI
|
35 |
Woodhams R, Ramadan S, Stanwell P, et al. Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics 2011;31:1059-1084
DOI
|
36 |
Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G, Moschetta M. Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): an accurate and alternative strategy for detecting and differentiating breast lesions. Magn Reson Imaging 2015;33:951-955
DOI
|